Who we are
We are a boutique media and research firm. Our research method involves sifting through large amounts of information in the public domain published by experts, then using our regular meetings and interviews with founders and industry participants to validate and boost our findings.
What we do
We educate and inform investors about disruptive technologies such that investment capital is directed towards those technologies that make the world a better place. We share insights about disruptive technology investments in a language that is future-proof and easy to understand – no financial jargon or technobabble. We write about startups, investable securities, market trends, and investment strategies in 12 key themes for an audience of retail and institutional investors, venture capitalists, corporates, management consultants, and entrepreneurs.
Why we do it
We give a voice to great ideas of the future, calling out anything that’s empty hype or a scam. True tech innovation makes everyone’s lives better, and we want to play our part in that. We also immensely enjoy learning from people smarter than us.
What we offer
For investors, both retail and institutional, our Nanalyze Premium subscription provides access to all premium research articles covering disruptive technology stocks and ETFs. Annual subscribers also receive access to our in-depth investment reports and tools including The Nanalyze Disruptive Tech Stock Portfolio Report. In our premium articles and reports, we evaluate stocks, ETFs, alternative assets, and other investment vehicles that allow investors to get exposure to 12 disruptive technologies and more than 70 related technology themes. More information on how we evaluate potential investments can be found in The Nanalyze Disruptive Tech Investing Methodology.
For startups and public relations/communications agencies, we offer Nanalyze Content Marketing, a service that helps companies articulate their exciting story to a broad audience of readers across the globe. We also provide custom research services for companies or agencies. If you’re interested to work with Nanalyze on custom research projects, please email us directly at info[at]nanalyze[dot]com.
Founded in 2003, Nanalyze started as a forum where investors could share information on companies involved in nanotechnology. Nanalyze was key in distributing objective information that helped differentiate real nanotechnology companies from “pump and dump” OTC stocks that attempted to capitalize on the hype surrounding nanotechnology. Today Nanalyze has moved to a publishing format so that our readers can better access information that will help them make more informed investment decisions.
As Nanalyze writers, we are a diverse group of individuals who collectively run the gamut when it comes to background, country of origin, work experience, education, race, gender, sexuality, and just about every other way you can slice and dice a population. The one thing we all have in common is a fascination for technology, a strong intellectual curiosity, an acceptance of our editorial guidelines, and the desire to help our fellow investors. We stand together as a single unified voice, calling things as we see them, while providing factual, insightful content to our lovely readers.
This website provides information about the stock market and other investments. This website does not provide investment advice and should not be used as a replacement for investment advice from a qualified professional. This website is for informational purposes only. The writers on this website are not registered investment advisors and do not offer investment advice. You, the reader, bear responsibility for your own investment decisions and should seek the advice of a qualified securities professional before making any investment.
Nanalyze currently has major affiliate relationships with Interactive Brokers, Amazon.com, and Ally Invest. We also have minor affiliate relationships with Ancestry.com, Betterment, GeneByGene, Blooom, SmileDirectClub, and other companies.
Many of the offers that appear on this site are from companies from which Nanalyze receives compensation. This compensation may impact how and where products appear on this site (including, for example, the order in which they appear). Nanalyze does not include all companies or all offers that may be available in the marketplace.
Editorial Note: Any opinions, analyses, reviews or recommendations expressed on this page are those of the author’s alone, and have not been reviewed, approved or otherwise endorsed by any Advertiser.
Some Nanalyze articles are written by finance professionals who may at times take positions in various companies or investment products discussed on this site.